跳至内容
当前位置: 首页 产品中心 分析试剂 生物试剂 PKI (14-22) amide (myristoylated) (trifluoroacetate salt)|34431-1 mg
PKI (14-22) amide (myristoylated) (trifluoroacetate salt)|34431-1 mg
图片仅供参考,具体产品以实物为准!

PKI (14-22) amide (myristoylated) (trifluoroacetate salt)|34431-1 mg

34431-1 mg
PKI (14-22) amide (myristoylated) (trifluoroacetate salt)
¥ 2881.0
¥ 2881.0
1 mg
萘析精选
见详情
− +
0
PKI (14-22) amide (myristoylated) (trifluoroacetate salt)介绍:

产品名称:
PKI (14-22) amide (myristoylated) (trifluoroacetate salt)
别名:
Myr-Gly-Arg-Thr-Gly-Arg-Arg-Asn-Ala-Ile-NH2|Myr-GRTGRRNAI-NH2|Myristoylated PKI-(14-22)-amide|PKI-(Myr-14-22)-amide
产品描述:
A PKA inhibitor; inhibits PKA activity in mouse brain or spinal cord lysates at 75 µM; reduces IgG-dependent phagocytosis of heat-killed S. cerevisiae by isolated human neutrophils; inhibits replication of several strains of Zika virus, including IbH 30656, MR766, H/FP/2013, and PRVABC59, in HUVECs (IC50s = 17.75, 22.29, 34.09, and 19.19 µM, respectively); increases latency to tail withdrawal in the tail-flick test in morphine-tolerant mice at 2.5 nmol, i.c.v.
保存温度:
-20
运输温度:
-20
预期分子量:
1209.4887
产品形式:
A solid
有效期:
1460
纯度:
≥98%
分子式:
C53H100N20O12 • XCF3COOH

本公司销售的所有产品仅供实验科研使用,不用于人体及临床诊断。

暂无标准解读内容
暂无常见问题内容